Ngā hua rapu - Michèle Cavo
- E whakaatu ana i te 1 - 20 hua o te 182
- Haere ki te Whārangi Whai Ake
-
1
Imaging in multiple myeloma: How? When? mā Elena Zamagni, Paola Tacchetti, Michèle Cavo
I whakaputaina 2018Revisão -
2
-
3
Staging of chronic lymphocytic leukemia mā Michele Baccarani, Michèle Cavo, Marco Gobbi, F. Lauria, S Tura
I whakaputaina 1982Artigo -
4
Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy mā Simona Soverini, Manuela Mancini, Luana Bavaro, Michèle Cavo, Giovanni Martinelli
I whakaputaina 2018Revisão -
5
Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years mā Francesca Palandri, Nicola Polverelli, Daria Sollazzo, Marco Romano, Lucia Catani, Michèle Cavo, Nicola Vianelli
I whakaputaina 2016Artigo -
6
PGE<sub>2</sub>-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit an<i>In Vitro</i>Antileukemic Immune Response mā Sara Trabanelli, Mariangela Lecciso, Valentina Salvestrini, Michèle Cavo, Darina Očadlíková, Roberto M. Lemoli, Antonio Curti
I whakaputaina 2015Artigo -
7
-
8
The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia mā Marilena Ciciarello, Giulia Corradi, Federica Loscocco, Giuseppe Visani, Federica Monaco, Michèle Cavo, Antonio Curti, Alessandro Isidori
I whakaputaina 2019Revisão -
9
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation mā Francesca Bonifazi, Francesco Barbato, Federico Ravaioli, Mariarosaria Sessa, Irene Defrancesco, Mario Arpinati, Michèle Cavo, Antonio Colecchia
I whakaputaina 2020Revisão -
10
The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling mā Dorian Forte, Valentina Salvestrini, Giulia Corradi, Lara Rossi, Lucia Catani, Roberto M. Lemoli, Michèle Cavo, Antonio Curti
I whakaputaina 2016Artigo -
11
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients mā Valentina Salvestrini, Gabriele Conti, Federica D’Amico, Gianluca Cristiano, Marco Candela, Michèle Cavo, Silvia Turroni, Antonio Curti
I whakaputaina 2025Artigo -
12
-
13
-
14
Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell su... mā Giulia Corradi, Carmen Baldazzi, Darina Očadlíková, Giovanni Marconi, Sarah Parisi, Nicoletta Testoni, Carlo Finelli, Michèle Cavo, Antonio Curti, Marilena Ciciarello
I whakaputaina 2018Artigo -
15
Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy mā Michèle Cavo, Elena Zamagni, Claudia Cellini, Patrizia Tosi, Delia Cangini, Michela Cini, Lelia Valdré, Gualtiero Palareti, Luciano Masini, S Tura, Michele Baccarani
I whakaputaina 2002Carta -
16
Solitary plasmacytoma of bone and extramedullary plasmacytoma: Two different entities? mā Piero Galieni, Michèle Cavo, Giuseppe Avvisati, Alessandro Pulsoni, Rosanna Falbo, M. A. Bonelli, Domenico Russo, Maria Teresa Petrucci, Alessandro Bucalossi, S Tura
I whakaputaina 1995Artigo -
17
A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies mā Marta Stanzani, Russell E. Lewis, Mauro Fiacchini, Paolo F. Ricci, Fabio Tumietto, Pierluigi Viale, Simone Ambretti, Michele Baccarani, Michèle Cavo, Nicola Vianelli
I whakaputaina 2013Artigo -
18
Comparison of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) with Standard of Care for Patients from Latin America with Newly Diagnosed Multiple Myeloma (NDMM) Who... mā Vânia Hungria, Déborah Martı́nez-Baños, María‐Victoria Mateos, Meletios Α. Dimopoulos, Michèle Cavo, Bart Heeg, Annette Lam, Gerardo Machnicki, Jianming He, Mariana Fernandez
I whakaputaina 2019Artigo -
19
Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an <i>ad hoc</i>... mā Valerio De Stefano, Alessandra Larocca, Monica Carpenedo, Michèle Cavo, Francesco Di Raimondo, Anna Falanga, Massimo Offidani, Maria Teresa Petrucci, Marco Ruggeri, Roberto Santi, Giovanni Barosi
I whakaputaina 2022Artigo -
20
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+... mā Roberto M. Lemoli, Alessandra Fortuna, MR Motta, Simonetta Rizzi, Valentina Giudice, A Nannetti, Giovanni Martinelli, Michèle Cavo, Marilina Amabile, Serena Mangianti, M Fogli, Roberto Conte, S Tura
I whakaputaina 1996Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Multiple myeloma
Oncology
Surgery
Biology
Lenalidomide
Gastroenterology
Bortezomib
Transplantation
Dexamethasone
Immunology
Bone marrow
Genetics
Melphalan
Cancer research
Confidence interval
Intensive care medicine
Clinical trial
Thalidomide
Adverse effect
Physics
Autologous stem-cell transplantation
Chemotherapy
Disease
Environmental health
Gene
Leukemia
Myeloid leukemia
Population